Filana TherapeuticsFLNA
13F holders, Q2 2026 (June 30)1holders −1
0new positions
0sold out
$1.20avg. 13F price*
At the end of Q2 2026, 1 institutions reported holding Filana Therapeutics Inc. (FLNA) in their 13F filings, down 1 from Q1 2026. 0 opened new positions and 0 sold out. The largest holder was Byrne Asset Management LLC ($48).
- Company
- Filana Therapeutics Inc.
- CUSIP
- 359528205
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| Byrne Asset Management LLC | 0.00% | No change | 40 | $48 |
"% of holder's portfolio" is FLNA's weight in each manager's 13F, not the share of Filana Therapeutics Inc. the manager owns.